Innovative oral delivery strategies for the treatment of metabolic gastrointestinal disorders

About
One of the greatest challenges in oral drug delivery involves the development of new drug delivery systems that enable the absorption of macromolecules/biologics into the systemic circulation at therapeutically relevant concentrations. During the last years, my group has been working on the development of innovative delivery strategies as a platform for the oral delivery of macromolecules in the treatment of metabolic gastrointestinal disorders, like type 2 diabetes diabetes, metabolic-dysfunction steatotic liver disease or inflammatory bowel disease.

Bio
Dr Beloqui’s main research interests are the investigation of the oral drug delivery route (especially focused on the oral delivery of biologics) and the interaction of the drug delivery system with the gastrointestinal epithelium. She has received multiple scholarships and prizes, including the Galien Prize 2021 in Belgium, the Endocrinology, Diabetes and Metabolism Prize 2023 from the Belgian National Funds of Research, the Rising Woman in Science award from the Controlled Release Society in 2024, and the prestigious ERC starting and proof of concept grants from the European Research Council. She also serves as Associate Editor for the Journal of Controlled Release.

Hosted by PI Noemi Csaba. Natural Polymers and Biomimetics Group, CiMUS

Certificates of attendance will be provided upon request at cimus.xestion [at] usc.es (cimus[dot]xestion[at]usc[dot]es). Please do not forget to enter your name and surname in the printout given during the lecture.